Sex- and age-related antihypertensive effects of Amlodipine

American Journal of Cardiology

Volumn 77, Issue 9, 1996, Pages 713-722

  Kloner, Robert A ^a   Sowers, James R ^b   DiBona, Gerald F ^b   Gaffney, Michael ^b   Wein, Marilee ^b  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; LIPID; LIPOPROTEIN; URIC ACID;

ADULT; AGE; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG SAFETY; EDEMA; ESSENTIAL HYPERTENSION; ETHNIC DIFFERENCE; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; VERTIGO;

EID: 0030004863     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89205-3     Document Type: Article

References (30)

1. Burges RA, Dodd MG. Amlodipine. Cardiovasc Drug Rev 1990;8:25-44.
2. Mroczek WJ, Burris JF, Allenby KS. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1988;12(suppl 7):S79-S84.
3. Frishman WH, Brobyn R, Brown RD, Johnson BF, Reeves RL, Wombolt DG. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension. J Cardiovasc Pharmacol 1988;12(suppl 7):S103-S106.
4. Taylor SH. Usefulness of amlodipine for angina pectoris. Am J Cardiol 1994;73:28A-33A.
5. Chahine RA, Feldman RL, Giles TD, Raizner AE, Weiss RJ, Nicod P, and the Investigators of Study 160. Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. Am Heart J 1989;118:1128-1130.
6. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR, for the Treatment of Mild Hypertension Study Research Group. Treatment of mild hypertension study: final results. JAMA 1993;270:713-724.
7. NDTI™ (basedon 1994 data), IMS America, Ltd. 1995. Plymouth Meeting, PA.
8. Physicians' Desk Reference. 48th ed. Montvale, NJ: Medical Economics Data Production Co; 1994. Production information for amlodipine besylate.
9. Webster J, Robb OJ, Jeffers TA, Scott AK, Petrie JC, Tyler HM. Once daily amlodipine in the treatment of mild to moderate hypertension. Br J Clin Pharmacol 1987;24:713-719.
10. Heber ME, Brigden G, Al-Khawaja I, Raftery EB. 24-hour blood pressure control with the once daily calcium antagonist, amlodipine. Br J Clin Pharmacol 1989;27:359-365.
11. Burris JF, Ames BP, Applegate WB, Ram CVS, Davidov ME, Mroczek WJ. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 1988;12(suppl 7):S98-S102.
12. de Bruijn B, Cocco G, Tyler HM, and Coinvestigators. Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension. J Cardiovasc Pharmacol 1988;12(suppl 7):S107-S109.
13. Lorimer AR, Smedsrud T, Walker P, Tyler HM. Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 1988;12(suppl):S89-S93.
14. Englert R, Beressem P, von Manteuffel E, Stafunsky M, Kramar M. An open, parallel, comparative evaluation of amlodipine and nitrendipine in the monotherapeutic treatment of mild and moderate essential hypertension. J Cardiovasc Pharmacol 1991;17(suppl 1):S22-S24.
15. Waeber B, Borges ET, Christeler P, Guillaume-Gentil M, Hollenstein U, Mannhart M. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action. Cardiology 1992;80(suppl 1):46-53.
16. Velasco M, Urbina A, Silva H, Fonesca R, Guevara J, Hernandez R, Hernandez Pieretti O. A double-blind, parallel, comparative evaluation of amlodipine vs. captopril in the monotherapeutic treatment of mild and moderate essential hypertension. J Cardiovasc Pharmacol 1991;17(suppl 1):S19-S21.
17. Lacourcière Y, Poirier L, Provencher P. Comparison of the effects of amlodipine and captopril on clinic and ambulatory blood pressure. J Hum Hypertens 1992;6(suppl 1):S25-S28.
18. Omvik P, Thawlow E, Herland OB, Eide I, Midha R, Turner RR. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study. J Hypertens 1993;11:103-113.
19. Rofman BA. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension. J Cardiovasc Pharmacol 1988;12(suppl 7):S94-S97.
20. Varrone J, and the Investigators of study AML-NY-86-002. The efficacy and safety of amlodipine in the treatment of mild and moderate essential hypertension in general practice. J Cardiovasc Pharmacol 1991;17(suppl 1):S30-S33.
21. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
22. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
23. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med 1992;152:56-64.
24. Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, Swiderski DM, Wheat ME, Williams S. Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med 1991;115:287-293.
25. Lerner DJ, Kannel WB. Patterns of coronary disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-390.
26. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program, II. Mortality by race, sex and age. JAMA 1979;242:2572-2577.
27. Schnall P, Alderman MH, Kern R. An analysis of the HDFP trial. Evidence of adverse effects of antihypertensive therapy on white women with moderate and severe hypertension. NY State J Med 1984;84:299-301.
28. Management Committee of the Australian Therapeutic Trial in Mild Hypertension. The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980;1:1261-1267.
29. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985;291:197-204.
30. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.